Teva Latest To Recall Valsartan-Containing Hypertension Drug

Mealey's (December 4, 2018, 3:14 PM EST) -- SILVER SPRING, Md. — Teva Pharmaceuticals on Nov. 27 became the eighth drug company to voluntarily recall valsartan-containing drugs because of the presence of N-nitrosodimethylamine (NDMA), a possible human carcinogen, the Food and Drug Administration announced....

Related Sections